Episodes

  • Intra Energy Corp identifies lithium and gold systems at MHH

    Intra Energy Corp identifies lithium and gold systems at MHH
    Sep 4 2024
    Intra Energy Corporation Ltd (ASX: IEC) principal geologist Todd Hibberd joins Proactive’s Tylah Tully to talk through results from a 1,960-metre reconnaissance drilling program at the Maggie Hays Hill (MHH) Project in the Lake Johnston Greenstone Belt, Western Australia. The company has identified large-scale lithium-caesium-tantalum (LCT) and gold systems. The LCT system extends over two kilometres with lithium grades peaking at 0.24%, alongside niobium and tantalum concentrations reaching 499 ppm and 788 ppm, respectively. Drilling tested seven pegmatites across 1,300 metres, revealing a broad LCT system enriched in several elements. Future efforts will aim to locate the core of the lithium system through additional geochemical analysis and further drilling, especially in untested areas to the west, east and north of the initial targets. The gold system, identified in the northern and central targets, exhibited low-grade mineralisation. Best results from the northern area included 2 metres at 0.3 g/t gold and 19 metres at 0.1 g/t gold, with notable base metal enrichment. While mineralisation was confirmed at both east and west reefs, the narrow and variable gold deposits suggest no further exploration is planned for these reefs. #Proactiveinvestors #IntraEnergyCorp #ASX #Lithium #Gold #Tantalum #Niobium #Caesium #MaggieHaysHill #Exploration #Mining #WesternAustralia #Pegmatites #GeologicalSurvey #MineralResources #IntraEnergyCorp #MiningNews #LCTSystem #GoldExploration #LakeJohnston #ReconnaissanceDrilling #RareMetals #Mineralisation
    Show more Show less
    3 mins
  • Race Oncology completes board renewal to drive next phase of growth

    Race Oncology completes board renewal to drive next phase of growth
    Sep 4 2024
    Race Oncology Ltd (ASX: RAC, OTC: RAONF) executive chair Dr Peter Smith joins Proactive’s Tylah Tully to discuss the latest updates at the company. It has completed a board renewal process, marking a significant milestone as the company prepares for its next phase of development. The company expressed gratitude to non-executive chair Mary Harney and non-executive director and former CEO/MD Phil Lynch for their four years of service. As part of the renewal, Dr Smith has been appointed as the executive chair, while Dr Daniel Tillett, the current CEO, will also take on the role of managing director. Additionally, Dr Serge Scrofani has joined the board as an independent non-executive director, bringing more than 28 years of experience in the healthcare sector, including key strategic roles at CSL. Dr Scrofani’s extensive experience in research, strategy and corporate development, particularly in driving strategic initiatives and executing major mergers and acquisitions, is expected to play a pivotal role in Race Oncology’s future. Currently, Dr Scrofani is the principal of Poplar Advisory and he serves on the boards of the Burnet Institute and The Centre for Eye Research. He also holds a PhD in Structural Biology and an MBA from Melbourne Business School. #Proactiveinvestors #RaceOncology #ASX #BoardRenewal, #HealthcareLeadership, #Bisantrene, #CancerTherapies, #ASXNews, #CorporateDevelopment, #StrategicLeadership, #Pharmaceuticals, #HealthcareSector, #BiotechNews, #ExecutiveAppointments, #MedicalResearch, #CorporateStrategy, #HealthcareInnovation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    6 mins
  • Elixir Energy confirms upper zone flow at Daydream-2

    Elixir Energy confirms upper zone flow at Daydream-2
    Sep 4 2024
    Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) managing director Neil Young joins Proactive’s Tylah Tully to discuss it’s Daydream-2 well progress, located at the Project Grandis site in Queensland. The company has confirmed a production logging tool (PLT) has been used to evaluate the majority of the key stimulated zones of the Daydream-2 well. The analysis confirms that the upper zones are contributing to the flow, though the lower zone is currently dominating. Fluid and proppant accumulation at the bottom of the well is affecting the optimal flow rate. The company plans to bring back the Coil Tubing Unit (CTU), which is currently deployed with a neighbouring operator, to the Daydream-2 site. This will allow for nitrogen lift and clean-out procedures to improve the flow rate. This work is expected to occur before the end of the month but depends on the pace of operations at the neighbouring site. Young expressed satisfaction with the confirmation of flow from the upper zones, despite a slight delay in operations. He highlighted that the delays are due to increased activity in the Taroom Trough, which is becoming increasingly significant for Australia's gas supply. #Proactiveinvestors #ASX #ElixirEnergy, #Daydream2, #ProjectGrandis, #QueenslandGas, #TaroomTrough, #EnergyExploration, #GasFlow, #CoilTubingUnit, #NitrogenLift, #NeilYoung, #FlowTesting, #Wellbore, #UpperZones, #LowerZones, #AustraliaEnergy, #GasSupplies, #ProductionLoggingTool, #Proppant, #CleanOut, #HecticPace #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    4 mins
  • OzAurum Resources identifies new niobium anomaly at Salitre in Brazil

    OzAurum Resources identifies new niobium anomaly at Salitre in Brazil
    Sep 4 2024
    OzAurum Resources Ltd (ASX:OZM) has identified a new niobium anomaly at its 100%-owned Salitre Project in Brazil based on recent soil sampling results. The anomaly spans a strike length of 1 kilometre with peak niobium values reaching 190 ppm. This discovery was part of a reconnaissance geological fieldwork and soil sampling program aimed at exploring circular features identified through hyperspectral interpretation. The program detected anomalous niobium mineralisation in soil accompanied by ultraviolet (UV) anomalies indicative of carbonatite intrusions, which are key sources of niobium and rare earth elements (REE). The highest total rare earth oxide (TREO) value recorded was 614 ppm. Salitre is within the Alto Paranaba Magmatic Province (APMP) in Brazil, known for its carbonatite intrusions that produce 97% of the world’s niobium. OzAurum plans follow-up soil sampling over a 1.2-square-kilometre area and is prepared to begin drilling once environmental permits and landholder approvals are obtained. The company views the Salitre and Catalao projects as significant exploration opportunities within APMP, with ongoing evaluations of other prospects, including lithium, in the region. #ProactiveInvestors #OzAurum #ASX #Niobium #SalitreProject #RareEarthElements #MineralExploration #BrazilMining #APMP #CarbonatiteIntrusions #GeologicalSurvey #UVAnomalies #SoilSampling #MiningNews #REEs #EnvironmentalPermits #DiamondDrilling #BrazilResources #MiningProjects #ExplorationOpportunity #MineralResources #LithiumExploration #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    15 mins
  • International Graphite welcomes Prime Minister Albanese at Collie facility

    International Graphite welcomes Prime Minister Albanese at Collie facility
    Sep 4 2024
    International Graphite Ltd (ASX: IG6) managing director and CEO Andrew Worland join’s Proactive’s Tylah Tully after recently hosting Prime Minister Anthony Albanese at its processing and research and development facility in Collie, Western Australia. The visit highlighted the company's significant contributions to Australia's critical minerals industry. The Collie facility is the first of its kind in Australia and forms a key part of International Graphite’s mine-to-market strategy, which includes the development of the Springfield Graphite Project - one of Australia’s largest graphite resources - and downstream processing at Collie. Prime Minister Albanese was accompanied by Federal Minister for Climate Change and Energy Chris Bowen, Assistant Minister Josh Wilson and several Western Australian Government representatives. The visit underscores the government’s support and interest in the growth of Australia’s critical minerals sector. The Collie facility operates as a pilot-scale micronising and spheroidising plant, producing graphite products for customer testing in various industries, including battery materials, defence, plastics, lubricants and aerospace. International Graphite plans to expand operations at the facility to a capacity of 4,000 tonnes of micronised product per year, supported by a $4.5 million grant from the WA Government awarded in April. #Proactievinvestors #InternationalGraphite #ASX #CollieFacility, #PrimeMinisterVisit, #GraphiteProduction, #CriticalMinerals, #ASXNews, #BatteryMaterials, #GraphiteProcessing, #AustralianMining, #GraphiteIndustry, #DownstreamProcessing, #GovernmentSupport, #MineToMarket, #SpringfieldGraphite, #EnergySector, #GraphiteMarket, #IndustrialMaterials, #GraphiteDemand, #MineralsProcessing, #WAIndustry #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    8 mins
  • Magnetite Mines raising up to $4.1 million to fund Razorback Project

    Magnetite Mines raising up to $4.1 million to fund Razorback Project
    Sep 4 2024
    Magnetite Mines Ltd (ASX:MGT) CEO Tim Dobson joins Proactive’s Tylah Tully to discuss its renounceable rights issue, offering eligible shareholders the opportunity to purchase one new share for every five held at a price of $0.20 per share. This initiative aims to raise approximately $4.1 million before costs with funds intended to support the future development of the Razorback Iron Ore Project in South Australia, specifically targeting the completion of the project’s definitive feasibility study (DFS) and securing necessary Mining Lease approvals. This rights issue follows a previous fundraising effort in July 2024, where the company raised $1.17 million from existing shareholders. Those shareholders are now eligible to receive one free option for every share purchased as a gesture of recognition for their support. The company sees the importance of strengthening its balance sheet to attract strategic partners and secure regulatory approvals for the Razorback project. #Proactiveinvestors #MagnetiteMines #ASX #RightsIssue #IronOre #MiningInvestment #RazorbackProject #Shareholders #CapitalRaising #FeasibilityStudy #MiningLease #StrategicPartnerships #JFEGroup #SteelIndustry #EquityMarkets #MiningFunding #ResourceDevelopment #AustralianMining #InvestorRelations #MiningNews #ProjectDevelopment #MiningOpportunities #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    9 mins
  • Synertec boosts revenue 26% in FY24 driven by Powerhouse

    Synertec boosts revenue 26% in FY24 driven by Powerhouse
    Sep 4 2024
    Synertec Corporation Ltd (ASX:SOP) managing director Michael Carroll and general manager of finance Yash Gala join Proactive’s Tylah Tully to discuss 2024 financial year results featuring a 26% increase in revenue and other income to $19.7 million. This growth was primarily driven by the expansion of its engineering services and deployment of its Powerhouse micro-grid renewable energy and storage solution. The company successfully rolled out three Powerhouse units during the fiscal year, contributing $1.1 million to group revenue, and is currently engaging with 15 potential customers for future deployments. The Powerhouse units demonstrated superior performance with more than 99.9% uptime and no need for site visits or maintenance. Synertec has also formed an exclusive partnership with Siemens to support further development and market expansion of the Powerhouse technology. Since FY2021, Synertec’s revenue has increased 135%, reflecting the company’s expanding operational footprint and the growing contribution of Powerhouse technology through long-term contracts. The company recently completed a capital restructure and secured its first debt facility, providing $21 million in working capital for FY25. Synertec’s management emphasized their focus on strategy execution and their commitment to delivering significant value for shareholders as the technology and engineering businesses reach critical growth stages. Synertec is holding a webinar on Friday August 6 at 2pm to discuss its results and key achievements. #Proactiveinvestors #Synertec #ASX #RevenueGrowth, #Powerhouse, #RenewableEnergy, #ASXNews, #EngineeringServices, #MicroGrid, #TechnologyDevelopment, #SiemensPartnership, #BusinessExpansion, #FinancialResults, #SustainableEnergy, #ShareholderValue, #DebtFacility, #StrategicGrowth #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    10 mins
  • Theralase Technologies Announces Promising Preclinical Results for Ruvidar in Treating HSV-1

    Theralase Technologies Announces Promising Preclinical Results for Ruvidar in Treating HSV-1
    Sep 3 2024
    Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to share its lead drug formulation, Ruvidar, has shown significant preclinical effectiveness in destroying the Herpes Simplex Virus 1 (HSV-1), surpassing the current standard of care, Acyclovir. Acyclovir, widely used to manage HSV-1, does not cure the virus but helps to alleviate symptoms associated with herpes infections, such as cold sores, genital herpes, shingles, and chicken pox. DuMoulin-White highlighted that the global antiviral drug market is projected to reach around $71 billion by 2032, with approximately 3.7 billion people under age 50 infected with HSV-1. The preclinical findings indicate that Ruvidar is not only more potent than Acyclovir but also capable of preventing HSV-1 replication by an impressive 10 million-fold if administered one day post-infection—something Acyclovir fails to achieve. These promising results position Ruvidar as a potential game-changer in the treatment of HSV-1, offering hope for more effective management of this widespread virus. #proactiveinvestors #theralasetechnologiesinc #tsxv #tlt #otcqb #tftff #MedicalResearch #HealthcareInnovation #PatientCare #CancerResearch #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #proactiveinvestors #theralasetechnologiesinc #tsxv #tlt #otcqb #tftff #MedicalResearch #HealthcareInnovation #PatientCare #CancerResearch #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #Ruvidar #Acyclovir #Pharmaceuticals #Biotech #Oncology #ViralInfections #DrugDevelopment #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins